OpenVSafe by OpenVAERS
Search V-safe

UKD-18104-83992

3 vaccinations 1 coded response 24 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
957 / CA
Registered
2021-01-11
Relationship
Self
Race
Other
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-11
    Registered in v-safe
  2. 2021-01-11
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  4. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  5. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  7. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-01-20
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-25
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-01
    Dose 2 — Pfizer-BioNTech
  11. 2021-02-01
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea
    Adult check-in
  12. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work
    Adult check-in
  13. 2021-02-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches
    Adult check-in
  14. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  15. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  16. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  17. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  18. 2021-02-08
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-15
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-22
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-15
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-05
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-08-02
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-10-10
    Dose 3 — Pfizer-BioNTech
  27. 2022-02-01
    Survey response — 12 months, dose 2
    MedDRA: Abortion spontaneous, Uterine leiomyoma — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Fibroids and a miscarriage
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-02-01
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  29. 2022-02-04
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  30. 2022-10-10
    Health check-in — 12 months, dose 3
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-11Pfizer-BioNTech
22021-02-01Pfizer-BioNTech
32021-10-10Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-02-01 Successful
2022-02-04
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 11 — 12 months, dose 2

2022-02-01

Symptoms: Fibroids and a miscarriage

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SDUterine leiomyoma · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release